Suppr超能文献

肺炎链球菌:毒力因子、发病机制与疫苗

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

作者信息

AlonsoDeVelasco E, Verheul A F, Verhoef J, Snippe H

机构信息

Eijkman-Winkler Institute of Medical and Clinical Microbiology, University Hospital, Utrecht, The Netherlands.

出版信息

Microbiol Rev. 1995 Dec;59(4):591-603. doi: 10.1128/mr.59.4.591-603.1995.

Abstract

Although pneumococcal conjugate vaccines are close to being licensed, a more profound knowledge of the virulence factors responsible for the morbidity and mortality caused by Streptococcus pneumoniae is necessary. This review deals with the major structures of pneumococci involved in the pathogenesis of pneumococcal disease and their interference with the defense mechanisms of the host. It is well known that protection against S. pneumoniae is the result of phagocytosis of invading pathogens. For this process, complement and anticapsular polysaccharide antibodies are required. Besides, relatively recent experimental data suggest that protection is also mediated by the removal of disintegrating pneumococci and their degradation products (cell wall, pneumolysin). These structures seem to be major contributors to illness and death caused by pneumococci. An effective conjugate vaccine should therefore preferably include the capsular polysaccharide and at least one of these inflammatory factors.

摘要

尽管肺炎球菌结合疫苗已接近获批,但仍有必要更深入地了解导致肺炎链球菌发病和死亡的毒力因子。本综述探讨了参与肺炎球菌疾病发病机制的肺炎球菌主要结构及其对宿主防御机制的干扰。众所周知,针对肺炎链球菌的保护作用是入侵病原体被吞噬的结果。此过程需要补体和抗荚膜多糖抗体。此外,最近的实验数据表明,保护作用还通过清除解体的肺炎球菌及其降解产物(细胞壁、肺炎溶血素)介导。这些结构似乎是肺炎球菌所致疾病和死亡的主要因素。因此,一种有效的结合疫苗最好应包含荚膜多糖和这些炎症因子中的至少一种。

相似文献

1
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
Microbiol Rev. 1995 Dec;59(4):591-603. doi: 10.1128/mr.59.4.591-603.1995.
3
The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Vaccine. 2000 Dec 8;19 Suppl 1:S87-95. doi: 10.1016/s0264-410x(00)00285-1.
4
Molecular analysis of putative pneumococcal virulence proteins.
Microb Drug Resist. 1997 Spring;3(1):1-10. doi: 10.1089/mdr.1997.3.1.
6
Immunity to Streptococcus pneumoniae: Factors affecting production and efficacy.
Curr Opin Infect Dis. 2003 Jun;16(3):219-24. doi: 10.1097/00001432-200306000-00006.
8
Mechanisms of host defense against infection with Streptococcus pneumoniae.
Clin Infect Dis. 1992 Jan;14(1):251-62. doi: 10.1093/clinids/14.1.251.
9
Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
PLoS One. 2017 Jun 6;12(6):e0179159. doi: 10.1371/journal.pone.0179159. eCollection 2017.
10
Pneumococcal virulence factors and host immune responses to them.
Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):479-90. doi: 10.1007/BF02113425.

引用本文的文献

1
Routine immunization against and type B and antibiotic consumption in India: a dynamic modeling analysis.
Lancet Reg Health Southeast Asia. 2024 Oct 16;31:100498. doi: 10.1016/j.lansea.2024.100498. eCollection 2024 Dec.
2
Species and Culturable Microorganism Co-Infestations in Patients with Blepharitis.
Life (Basel). 2023 Aug 29;13(9):1827. doi: 10.3390/life13091827.
3
Emerging vaccine strategies against the incessant pneumococcal disease.
NPJ Vaccines. 2023 Aug 17;8(1):122. doi: 10.1038/s41541-023-00715-w.
5
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods.
Bioengineering (Basel). 2022 Dec 6;9(12):774. doi: 10.3390/bioengineering9120774.
6
Biochemical Characterization and Synthetic Application of WciN and Its Mutants From Serotype 6B.
Front Chem. 2022 Jun 15;10:914698. doi: 10.3389/fchem.2022.914698. eCollection 2022.
10
Contribution of N-lysine Acetylation towards Regulation of Bacterial Pathogenesis.
mSystems. 2021 Aug 31;6(4):e0042221. doi: 10.1128/mSystems.00422-21. Epub 2021 Aug 24.

本文引用的文献

3
THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.
J Exp Med. 1931 Jun 30;54(1):73-89. doi: 10.1084/jem.54.1.73.
7
The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells.
Infect Immun. 1993 Apr;61(4):1538-43. doi: 10.1128/iai.61.4.1538-1543.1993.
8
Toxicity of pneumolysin to pulmonary alveolar epithelial cells.
Infect Immun. 1993 Apr;61(4):1352-8. doi: 10.1128/iai.61.4.1352-1358.1993.
9
Towards a comprehensive view of immunoglobulin class switching.
Immunol Today. 1993 Jan;14(1):15-7. doi: 10.1016/0167-5699(93)90318-F.
10
Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):110-9. doi: 10.1016/0091-6749(93)90303-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验